Publisher: John Wiley & Sons Inc
E-ISSN: 1532-6535|103|2|188-192
ISSN: 0009-9236
Source: CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.103, Iss.2, 2018-02, pp. : 188-192
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Challenges and opportunities of pharmacogenetics in drug development
By March Ruth
Personalized Medicine, Vol. 3, Iss. 2, 2006-05 ,pp. :
Assessment in transition: Options, challenges, and future directions
PEDIATRIC TRANSPLANTATION, Vol. 19, Iss. 5, 2015-08 ,pp. :
Assumptions, challenges, and future directions in cumulative impact analysis
Best Practices in Mental Health, Vol. 4, Iss. 10, 2013-10 ,pp. :